Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer

Figure 1

Comparison of study subjects’ serological indicators (x ± s). Note: (a) the CA15-3 level; (b) the CYFRA21-1 level; and (c) the TFF1 level.

(a)

(b)

(c)